The degradation and functional loss of E-cadherin are described as key molecular alterations that occur during tumor progression and are mediated by a variety of mechanisms, including transcriptional repression, epigenetic silencing, inactivating mutation, enhanced degradation, endocytosis, and proteolytic cleavage [44,45]. The gene discussed is CDH1; the disease is neoplasm.